BioSequence's Acquisition

BioSequence was acquired by OncoDNA on February 23, 2017.

BioSequence provides a personalized oncological diagnostics service through genetic testing, looking at each patient case to offer solutions that adapt to their individual characteristics by improving…

Articles about BioSequence's Acquisition: